Interdisciplinary Management of Perianal Crohn's Disease

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Perianal disease is a common manifestation of Crohn disease (CD) that results in significant morbidity and decreased quality of life. Despite several medical and surgical options, complex perianal CD remains difficult to treat. Before the advent of biologic therapy, antibiotics were the mainstay of medical treatment. Infliximab remains the most well-studied medical therapy for perianal disease. Surgical interventions are limited by the risk of nonhealing wounds and potential incontinence. When treatment options fail, fecal diversion or proctectomy may be necessary. Stem cell therapies may offer improved results and seem to be safe, but are not yet widely used.

Original languageEnglish (US)
Pages (from-to)547-562
Number of pages16
JournalGastroenterology Clinics of North America
Volume46
Issue number3
DOIs
StatePublished - Sep 1 2017

Keywords

  • Combined medical and surgical management
  • Crohn's disease
  • Perianal fistulizing disease

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Interdisciplinary Management of Perianal Crohn's Disease'. Together they form a unique fingerprint.

  • Cite this